ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
9 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
1.3K
|
357K
|
9
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
upthedell
|
63 |
20K |
5 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
63
|
20K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
upthedell
|
157 |
39K |
5 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
157
|
39K
|
5
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
upthedell
|
63 |
20K |
6 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
63
|
20K
|
6
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
upthedell
|
63 |
20K |
13 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
63
|
20K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
upthedell
|
157 |
39K |
4 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
157
|
39K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Deborah Ambrosini appointed as CFO & Company Secretary
|
|
upthedell
|
33 |
10K |
1 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
33
|
10K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Deborah Ambrosini appointed as CFO & Company Secretary
|
|
upthedell
|
33 |
10K |
3 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
33
|
10K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Deborah Ambrosini appointed as CFO & Company Secretary
|
|
upthedell
|
33 |
10K |
9 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
33
|
10K
|
9
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
5 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
1.3K
|
357K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
5 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
1.3K
|
357K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
18 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
1.3K
|
357K
|
18
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
upthedell
|
129 |
36K |
21 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
129
|
36K
|
21
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
upthedell
|
129 |
36K |
10 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
129
|
36K
|
10
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
upthedell
|
366 |
122K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
366
|
122K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
upthedell
|
238 |
69K |
8 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
238
|
69K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
upthedell
|
238 |
69K |
13 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
238
|
69K
|
13
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
upthedell
|
366 |
122K |
11 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
366
|
122K
|
11
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
upthedell
|
366 |
122K |
3 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
366
|
122K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: US Patent Granted for ATL1102 in Duchenne muscular dystrophy
|
|
upthedell
|
7 |
2.8K |
9 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
7
|
2.8K
|
9
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
upthedell
|
366 |
122K |
4 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
366
|
122K
|
4
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
upthedell
|
366 |
122K |
2 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
366
|
122K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: WHO selects proposed INN for ATL1102
|
|
upthedell
|
16 |
6.4K |
7 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
16
|
6.4K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
upthedell
|
58 |
18K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
58
|
18K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
upthedell
|
58 |
18K |
20 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
58
|
18K
|
20
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
8 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
1.3K
|
357K
|
8
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.3K
|
357K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
8 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.3K
|
357K
|
8
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.3K
|
357K
|
5
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
upthedell
|
366 |
122K |
6 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
366
|
122K
|
6
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
upthedell
|
366 |
122K |
6 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
366
|
122K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 Clinical Trial Update
|
|
upthedell
|
16 |
6.1K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
16
|
6.1K
|
5
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
upthedell
|
366 |
122K |
1 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
366
|
122K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
10 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
1.3K
|
357K
|
10
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.3K
|
357K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
4 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.3K
|
357K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
upthedell
|
1.3K |
357K |
7 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.3K
|
357K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Change of Registered Office and Principal Place of Business
|
|
upthedell
|
4 |
1.8K |
4 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
4
|
1.8K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Open House Meeting
|
|
upthedell
|
25 |
6.2K |
4 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
25
|
6.2K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
upthedell
|
115 |
33K |
4 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
115
|
33K
|
4
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
upthedell
|
1.0K |
313K |
1 |
04/02/24 |
04/02/24 |
ASX - By Stock
|
1.0K
|
313K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
upthedell
|
115 |
33K |
8 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
115
|
33K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
upthedell
|
115 |
33K |
8 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
115
|
33K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Phase IIA Final Data Published
|
|
upthedell
|
21 |
7.4K |
16 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
21
|
7.4K
|
16
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
upthedell
|
92 |
35K |
6 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
92
|
35K
|
6
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
upthedell
|
1.0K |
313K |
1 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
1.0K
|
313K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
upthedell
|
92 |
35K |
1 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
92
|
35K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
upthedell
|
92 |
35K |
4 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
92
|
35K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
upthedell
|
92 |
35K |
10 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
92
|
35K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
upthedell
|
92 |
35K |
2 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
92
|
35K
|
2
|
|